ViaDerma, Inc. (VDRM)
- Previous Close
0.0099 - Open
0.0095 - Bid --
- Ask --
- Day's Range
0.0099 - 0.0099 - 52 Week Range
0.0080 - 0.0180 - Volume
2,171,169 - Avg. Volume
1,649,212 - Market Cap (intraday)
83,765 - Beta (5Y Monthly) -0.18
- PE Ratio (TTM)
0.04 - EPS (TTM)
0.2800 - Earnings Date Apr 1, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
ViaDerma, Inc. operates as a specialty pharmaceutical company in the United States. It focuses on developing and marketing pharmaceutical products, as well as licensing its technology to companies in the pharmaceutical industry in various therapeutic areas. The company's lead product is Vitastem, a tetracycline-based topical antibiotic used for cuts, scrapes, wounds, infections, burns, acne, psoriasis, eczema, and minor injuries. It is also developing products in various fields of use, including topical antibiotics, toenail antifungal drugs, diabetic amputations, global acne, psoriasis, and eczema, as well as burns, anti-aging/wrinkle remover creams, medical cannabis, male-pattern baldness, skin cancer, erectile dysfunction, and pain management. The company was formerly known as Décor Products International, Inc. and changed its name to ViaDerma, Inc. in May 2014. ViaDerma, Inc. was incorporated in 2007 and is headquartered in Marina Del Rey, California.
viadermalicensing.com--
Full Time Employees
December 31
Fiscal Year Ends
Sector
Recent News: VDRM
Performance Overview: VDRM
Trailing total returns as of 4/24/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: VDRM
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: VDRM
Valuation Measures
Market Cap
--
Enterprise Value
--
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
--
Enterprise Value/Revenue
0.35
Enterprise Value/EBITDA
0.90
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-91.23%
Return on Equity (ttm)
--
Revenue (ttm)
44.69k
Net Income Avi to Common (ttm)
-1.52M
Diluted EPS (ttm)
0.2800
Balance Sheet and Cash Flow
Total Cash (mrq)
13.08k
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
688.4k
Company Insights: VDRM
VDRM does not have Company Insights